Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Keenan JC, Miller E, Jessurun J, Allen T, Kim HJ. IgG4-related lung disease: a case series of 6 patients and review of the literature. Sarcoidosis Vasc Diffuse Lung Dis. 2016;32(4):360-7.

Chiron D, Bellanger C, Papin A, Tessoulin B, Dousset C, Maiga S, et al. Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma. Blood. 2016;128(24):2808-2818.

Westblade LF, Mathison BA, Singer MS, Jerris RC, Caltharp SA. Photo Quiz: A 4-Year-Old Boy Vomits on His Sister. J Clin Microbiol. 2016;54(12):2845.

Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, et al. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. J Natl Cancer Inst. 2016;108(2).

Mathieu R, Klatte T, Lucca I, Mbeutcha A, Seitz C, Karakiewicz PI, et al. Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study. BJU Int. 2016;118(2):243-9.

Krebs S, Monti S, Seshan S, Fox J, Mannelli L. IgG4-Related Kidney Disease in a Patient With History of Breast Cancer: Findings on 18F-FDG PET/CT. Clin Nucl Med. 2016;41(8):e388-9.

Choe H, Sboner A, Beltran H, Nanus D, Tagawa ST. PO-43 - Differential coagulation factor expression in neuroendocrine prostate cancer (PC), metastatic castrate-resistant PC, and localized prostatic adenocarcinoma. Thromb Res. 2016;140 Suppl 1:S192.

Hipp JA, Jing X, Zarka MA, Schmitt AC, Siddiqui MT, Wakely P, et al. Cytomorphologic characteristics and differential diagnoses of lymphoepithelial carcinoma of the parotid. J Am Soc Cytopathol. 2016;5(2):93-99.

D'Alfonso TM, Subramaniyam S, Ginter PS, Mosquera JM, MacDonald TY, Noorzad Z, et al. Characterization of the leiomyomatous variant of myofibroblastoma: a rare subset distinct from other smooth muscle tumors of the breast. Hum Pathol. 2016;58:54-61.

Winer A, Janosky M, Harrison B, Zhong J, Moussai D, Siyah P, et al. Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study. Mol Cancer Ther. 2016;15(10):2370-2377.